Neurointervention Search

CLOSE


Instructions for authors

  • HOME
  • AUTHOR INFORMATION
  • Instructions for authors

  • Revised August, 2018

Table of Contents

1. Aims and Scope

Neurointervention, the official journal of the Korean Society of Interventional Neuroradiology, and the Asian-Australasian Federation of Interventional and Therapeutic Neuroradiology publishes original articles documenting interventional neuroradiology biannually on March 1st and September 1st. Neurointervention publishes articles related to research in and the practice of neurovascular diseases, including observational studies, clinical trials, epidemiology, health services and outcomes studies, and advances in applied (translational) and basic research.
The journal publishes full-length original papers, reviews, technical notes, brief report, case reports, and letters to the editor. Submitted manuscripts should not contain previously published material and should not be under consideration for publication elsewhere unless specific permission is obtained. The instructions for Neurointervention submissions are in accord with the “Uniform Requirements for Manuscripts Submitted to Biomedical Journals” of the International Committee of Medical Journal Editors (ICMJE; http://www.icmje.org).

2. Research and Publication Ethics

For policies on research and publication ethics not stated in these instructions, Guidelines on Good Publication (http://publicationethics.org/resources/guidelines) or Publication Ethics Policies for Medical Journals (http://wame.org/recommendations-on-publication-ethics-policies-for-medical-journals) can be applied.

Conflict of Interest
Conflicts of interest/disclosure statements, if applicable, must be completed with all submissions using the appropriate electronic form in the Contribution rules of the Journal homepage or the printed form in the Journal. Disclosure is not intended to prevent authors with potential conflicts of interest from contributing to Neurointervention; rather, it places on record any relationship that may exist with mentioned or competing products or firms. Disclosed information will be held in confidence during the review process and the Editors will determine the nature of any printed disclosure accompanying a published article. Authors are responsible for notifying the Journal of financial arrangements including, but not limited to, agreements for research support, speaker bureaus, consulting, or ownership interests.
Authorship
Neurointervention defines an "author" as a person whose participation in the work is sufficient for taking public responsibility for all portions of the content. Specifically, all authors should have made substantial contributions to all of the following: (1) Substantial contributions to the conception or design of the work, or the acquisition, analysis, or interpretation of data for the work; (2) Drafting the work or revising it critically for important intellectual content; (3) Final approval of the version to be published; and (4) Agreement to be accountable for all aspects of the work by ensuring that questions related to the accuracy or integrity of any part of the work are appropriately investigated and resolved (Defining the role of authors, ICMJE; http://www.icmje.org/recommendations/browse/roles-and-responsibilities/defining-the-role-of-authors-and-contributors.html).
If any persons do not meet the above criteria, they may be placed as contributors in the Acknowledgments section. Description of co-first authors or co-corresponding authors is also accepted, if the corresponding author believes that they equally to the article.
The corresponding author takes primary responsibility for communication with the journal during the manuscript submission, peer review, and publication process, and typically ensures that all the journal's administrative requirements, such as providing details of authorship, ethics committee approval, clinical trial registration documentation, and gathering conflict of interest forms and statements, are properly completed, although these duties may be delegated to one or more coauthors.
Ethics
Manuscripts involving examinations of volunteers and patients must include a statement that the trial protocol has been approved by an institutional ethics review board (IRB) and that the subjects gave informed consent in accordance with the standards of the Declaration of Helsinki in its revised version that the World Medical Association has developed as a statement of ethical principles for medical research involving human subjects, including research on identifiable human material and data (http://www.wma.net). Clinical studies that do not meet the Helsinki Declaration will not be considered for publication. Human subjects should not be identifiable, such that patients’ names, initials, hospital numbers, dates of birth, or other protected healthcare information should not be disclosed. For animal experiments, it is expected that investigators will adhere to the Guide for the Care and Use of Laboratory Animals (National Academy of Science; http://dels.nas.edu/).
Copyright and Permissions
Neurointervention only accepts manuscripts describing original research. The editorial office of Neurointervention does not accept duplicate submission or redundant publication. Redundant (or duplicate) publication is publication of a paper that overlaps substantially with one already published in print or electronic media as defined by updated ICMJE guidelines regarding allegations of scientific misconduct. If authors believe their manuscript may be redundant, they should ask about this in a letter to the editor accompanying their submission. In that letter, they should explain how their report overlaps with already published material, or how it differs. To help the editor determine the possibility of redundant publication, a copy of such published material may also be included. If excerpts from other copyrighted works are included, the author(s) must obtain written permission from the copyright owners and credit the source(s) in the article.
Clinical Trial Registration
Neurointervention requires investigators to register their clinical trials (other than phase 1 or small device feasibility trials) in a public trials registry. This requirement will lessen the chance of publication bias by making all trials (published or unpublished) available to clinicians, investigators, and the public, even those that are negative or reflect unfavorably on a research sponsor's product.
Editorial Policies
Manuscripts are examined by the editor and usually evaluated by peer reviewers assigned by the editor. Both clinical and basic articles will also be subject to statistical review when appropriate. Provisional or final acceptance is based on originality, scientific content, and topical balance of the journal. Manuscript decisions are based on the results of peer review, and to ensure that the process is unbiased, reviewers receive manuscripts with blind title pages. Decisions are communicated by e-mail, generally within 8 weeks. All rebuttals must be submitted in writing to the editorial office. Descriptions appearing in each article are the responsibility of the author and not of Neurointervention. The editorial board will continuously work to monitor publication ethics and check manuscripts to confirm originality.

3. Language, Units, and Abbreviations

The official language of this journal is English. For medical terms such as proper nouns, generic names of medicines, and units of measurement, use the original term. Abbreviations should be spelled out when first used in the text ─ for example, “dural arteriovenous fistula (DAVF)” ─ and the use of abbreviations should be kept to a minimum. This usage should conform to the rules found in the AMA Manual of Style: A Guide for Authors and Editors, 10th Edition (http://www.amamanualofstyle.com/). The use of standard international units is encouraged.

4. Submission of Manuscripts

Electronic submission is the only method of submitting manuscripts to Neurointervention. Authors must go to http://submit.neurointervention.org and log on to electronically submit a manuscript. Hard copy submissions will not be considered.
Following submission of a manuscript, the authors should send a copyright transfer form (http://neurointervention.org/authors/copyright_transfer_agreement.php) and conflict of interest discloser form (http://neurointervention.org/authors/conflict_of_interest.php) by upload to the e-submission system or by e-mail.

Dae Chul Suh, M.D., Ph.D.: Editor-in-Chief,
Editorial Office of Neurointervention,
#705-2C, 9 Gangnam-ro, Giheung-gu, Yongin-si, Gyeonggi-do 16977, KOREA
Tel: +82-31-994-4382
Fax: +82-70-4009-3667
e-mail: ksin@ksin.or.kr or dcsuh@amc.seoul.kr

5. General Manuscript Preparations

Manuscript Formatting
The title page, manuscript (including abstract, main text, references, and figure legends), figures, tables, and supplemental contents should be prepared as separated files.
  • Only Microsoft Word files will be accepted for review.
  • Page size of manuscript is A4 (210 × 297 mm).
  • Abstract, main text, references, and figure legends use a separate page.
  • Main text must be 1.5-spaced, including references and figure legends.
  • Body text size should be 12 pt.
  • All manuscript pages are to be numbered consecutively, beginning with the abstract as page 1.
  • The use of acronyms and abbreviations is discouraged and should be kept to a minimum. When used, they are to be defined where first used, followed by the acronym or abbreviation in parentheses.
  • The names and locations (city, state, and country) of manufacturers of equipment and non-generic drugs should be given.
  • In accordance with the Journal’s blinded review process, author/institutional information should be omitted or blinded from all content except the title page.

Title
The following items should be written on the title page

  • Full tile of the paper: Titles should be short, specific, and informative. A separate running title within 8 words should be provided.
  • The name of the principal and other authors, along with current positions. When authors with a different address are included, first write the name of the organization where the primary research was conducted and the names of the other organizations along with the authors’ names, listed in numerical order, with the numbering system beginning at the first organization.
  • Disclosure of funding received for this work
  • The source of financial support and industry affiliations of all those involved must be stated.
  • Corresponding author contact information, including the name, address, phone, and e-mail address of the author responsible for correspondence

Abstract

  • Describe each item separately in the following order.
  • Purpose: In 1 or 2 sentences, indicate the specific purpose of the article, and indicate why it is worthy of attention. The purpose stated here must be identical to the one given in the title of the paper and the introduction.
    Materials and Methods: Describe succinctly the methods used to achieve the purpose explained in the first paragraph, stating what was done and how bias was controlled, what data were collected, and how the data were analyzed.
    Results: The findings of the methods described in the preceding paragraph are to be presented here with specific data. All results should flow logically from the methods described.
    Conclusion: In 1 or 2 sentences, state the conclusion of the study. This must relate directly to the purpose of the papers, as defined in the first paragraph of the abstract.
  • Do not use reference citations.
  • Keywords: At the bottom of the abstract, write 3-6 index terms, according to the index words referred in Medical Subject Heading (MeSH) in Index Medicus or on the internet site https://www.ncbi.nlm.nih.gov/mesh.

Main Text

  • Introduction: Briefly describe the purpose of the investigation, including relevant background information.
  • Materials and Methods: Describe the research plan, the materials (or subjects), and the methods used, in that order. Explain in detail how the disease was confirmed and how subjectivity in observations was controlled. When experimental methodology is the main issue of the paper, describe the process in detail so as to allow for recreation of the experiment as closely as possible.
    Present these in a clear, logical sequence. Because biometrics involves variations in exact measurements, follow the rule of using statistics when experimentation is described. If tables are used, do not duplicate tabular data in the text, but do describe important trends and points.
  • Results: Work should be reported in SI units. Undue repetition in text and tables should be avoided. Comment on validity and significance of results is appropriate, but broader discussion of their implication is restricted to the next section. Subheadings that aid clarity of presentation within this and the previous section are encouraged.
  • Discussion: Observations pertaining to the results of research and other related materials should be interpreted for your readers. Emphasize new and important observations; do not merely repeat the contents of the results.
    Explain the meaning of the observed opinion along with its limits, and within the limits of the research results, connect the conclusion to the purpose of the research. In a concluding paragraph, summarize the results and their meaning.
  • Conclusion: Provide a brief summary of results with any important recommendations and finish with some sort of judgment about the topic.

Acknowledgments

  • List all grants pertinent to the paper. In addition, authors must state whether they have any personal or institutional financial interest in drugs, materials, or devices described in their submissions.
  • Concise acknowledgment of contributors not listed as authors is welcome.

References

  • All references should be cited in the text.
  • References are cited in consecutive numeric order in which they appear in the text by means of superscript Arabic numerals.
  • Use superscript numerals outside periods, commas, colons, and semicolons. Here are 2 examples:
    “Recent major randomized controlled trials (RCTs) using these new devices have now established endovascular treatment (EVT) as the standard treatment for patients presenting with emergent intracranial large vessel occlusions.4-8
    “Since balloon guide catheters can prevent distal embolization of the thrombus, 16,17 it was frequently used...”
  • Unpublished data should not be cited in the reference list, but parenthetically in the text; for example: (Smith DJ, personal communication), (Smith DJ, unpublished data).
  • Journal names should be abbreviated according to the Index Medicus.
  • All authors are to be listed when there are 6 or fewer; when there are 7 or more, the first 6 should be given, followed by ‘et al’.
  • After writing the authors’ last names first, the first letter of their first and middle names should be capitalized.
  • For all references, inclusive page numbers (eg, 111-114) are to be given.
  • The style and punctuation of references should follow the format illustrated in the following examples.

Print journal reference
Munich SA, Tan LA, Nogueira DM, Keigher KM, Chen M, Crowley RW, et al. Mobile real-time tracking of acute stroke patients and instant, secure inter-team communication - the join app. Neurointervention 2017;12:69-76

Publish-Ahead-of-Print reference:
Lauric A, Hippelheuser JE and Malek AM. Critical role of angiographic acquisition modality and reconstruction on morphometric and haemodynamic analysis of intracranial aneurysms. [published online ahead of print Jan 19, 2018] J Neurointerv Surg. 2018.

Book
Lasjaunias PL, Berenstein A, Ter Burgge KG. Surgical neuroangiography: Clinical vascular anatomy and variations, 2nd ed. Heidelberg: Springer; 2001

Chapter in a book
Berenstein A, Lasjaunias PL, Ter Burgge KG. Dural arteriovenous shunts. In: Berenstein A, Lasjaunias PL, Ter Burgge KG. Surgical neuroangiography: Clinical and endovascular treatment aspects in adults, 2nd ed. Heidelberg: Springer, 2004;3-147

Tables

  • For tables, Arabic numerals should be employed. The title of the table should be clearly stated in the form of a paragraph or sentence. The first letters of nouns and adjectives should be capitalized.
  • Tables are to be numbered in the order in which they are cited in the text.
  • Abbreviations should be defined in an explanatory note below each table.
  • Tables should be self-explanatory and readily comprehensible. Tables from previously published works should not be used.
  • Explanations for and abbreviations used in tables are included as footnotes. For footnotes, use the following symbols in the following order: *, †, ‡, §, ‖, ¶, **, ††, ‡‡, etc.

Figures

  • Submit all figures in BMP, JPG, or TIF format, separately from text. Electronic photographs must have a resolution of at least 300 dpi.
  • All figure parts relating to a patient should have the same figure number. In the case of multiple prints bearing the same number, use English letters after the numerals to indicate the correct order (example: Fig. 1A, Fig. 1B). Authors may wish to make written suggestions about the arrangement of illustrations.
  • If patient(s) are identifiable in a video, the authors must submit with the manuscript a completed Patient Permission form.

Legends

  • Legends should be numbered in the order in which they are cited, using Arabic numerals.
  • On a separate sheet of paper, write a description.
# Editorials, reviews, technical notes, clinical reports, brief report, and letters to editor: The abstract and main text do not have to conform to the structured format described above.

Supplemental Data

Video/audio submission guidelines:

  • Acceptable file formats: .mp4, .mov, .wmv, .mpg, .mpeg, or .avi (or .mp3, .wav for audio files). No Flash or streaming video files.
  • Minimum dimensions: 320 pixels wide by 240 pixels deep
  • Maximum length: 10 minutes
  • Verify that the videos are viewable in QuickTime or Windows Media Player.
  • If multiple video files are submitted, number them in the order in which they should be viewed.
  • If patient(s) are identifiable in the video, the authors must submit with the manuscript a Patient Permission form, completed and signed by the patient.

Other file types
In addition to the audio and video file types listed above, we can also accept the following file formats for supplementary materials:
.doc(x), .xls(x), .ppt(x), .pdf, .tiff, and .jpeg.

6. Manuscript Types

Original Paper

An original paper should provide new scientific information based on original research that is hypothesis-driven. This includes randomized controlled trials, intervention studies, outcome studies, cost effectiveness analyses, case-control series, surveys with a high response rate, and systematic reviews and statistical analyses. The text of original articles should be divided into sections with the following headings: Abstract, Introduction, Materials and Methods, Results, Discussion, References, Acknowledgment, Figure legends.
Abstract: Up to 300 words
Main text word count: up to 3500 words (excluding title page, abstract, references, tables, and legends)
Tables/Figures: up to 5 each
References: up to 35

Review

A review article should focus on a specific topic in a scholarly manner and will be published as a commissioned paper at the request of the editorial board. The abstract and main document don’t have to conform to the structured format.
Unstructured abstracts: up to 250 words
Main text word count: up to 5000 words
Tables/Figures: up to 10 each
References: up to 50

Technical Notes

Technical notes are articles with an emphasis on the novel technical aspects of related fields. These should be exclusively educational or technically innovative. It is encouraged to illustrate procedures or devices specifically and practically so as to share new techniques among the readers.
Unstructured abstracts: up to 250 words
Main text word count: up to 3000 words
Tables/Figures: up to 5 each
References: up to 20

Brief Report

Brief reports are similar to original research in that they follow the same rigor, format, and guidelines, but are designed for small-scale research or research that is in early stages of development. These may include preliminary studies that utilize a simple research design or a small sample size and that have produced limited pilot data and initial findings that indicate a need for further investigation.
Unstructured abstract: up to 250 words
Main text word count: up to 3000 words
Tables/Illustrations: up to 5 each
References: up to 20

Case series

Case series include detailed descriptions of unique cases (more than 3 subjects) to provide academic knowledge, presenting both classical and unusual presentations which may confront the practitioner. The main document consists of an introduction, the case series, and a discussion.
Unstructured abstract: up to 250 words
Main text word count: up to 3000 words
Tables/Illustrations: up to 5 each
References: up to 20

Letters to the Editor

Constructive criticism of a specific thesis published by Neurointervention is welcome. Letters dealing with subjects of general interest within the field of radiology or personal opinions on a specific subject within the realm of scientific study may also be accepted. An abstract is not required.
Main text word count: up to 1000 words
References: up to 4

Commentary

Commentary is to express opinions, to pose important questions, to share new ideas, and to debate current issues at the request of the editor(s).
Main text word count: up to 1000 words
References: up to 4

7. Review Process

Upon submission of a manuscript, the board of editors for Neurointervention will review the paper for appropriateness of content. The board of editors reserves the right to edit a manuscript for phrasing, style, and overall content at any stage prior to publication, while maintaining the scientific accuracy of the manuscript. The reviewed manuscripts are returned back to the corresponding author with comments and recommended revisions. Names and decisions of the referees are masked.

8. Submission of Revised Manuscripts

Revised manuscripts are submitted through the journal’s online manuscript submission site (http://submit.neurointervention.org) with a response letter which must indicate clearly what alterations have been made in response to the referees’ comments in a point-by-point fashion.

9. Introduction for Submission of Accepted Manuscript

Upon acceptance, the corresponding author should send the final version of the manuscript and a signed copyright transfer in advance to the editorial office by the e-submission system, e-mail, or Fax.

10. Proof Reading

The purpose of the proof is to check for typesetting or conversion errors and the completeness and accuracy of the text, tables, and figures. Substantial changes in content, eg, new results, corrected values, title, and authorship, are not allowed without the approval of the Editor.

  • Easy Advancement of a Large-Profile Microcatheter (Excelsior XT27™) by Parallel Use of Two Microguidewires For Stent Delivery. Neurointervention. 2016;11:24-29


ABOUT
ARTICLE CATEGORY

Browse all articles >

BROWSE ARTICLES
AUTHOR INFORMATION
Editorial Office
#705-2C, 9 Gangnam-ro, Giheung-gu, Yongin-si, Gyeonggi-do 16977, KOREA
Tel: +82-31-994-4382    Fax: +82-2-2275-9198    E-mail: ksin@ksin.or.kr                

Copyright © 2018 by Korean Society of Interventional Neuroradiology. All rights reserved.

Developed in M2community

Close layer
prev next